- Home
- REPL vs CRF Comparison
REPL vs CRF Comparison
Compare REPL & CRF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- CRF
- Stock Information
- Founded
- REPL 2015
- CRF 1973
- Country
- REPL United States
- CRF United States
- Employees
- REPL N/A
- CRF N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- CRF Finance/Investors Services
- Sector
- REPL Health Care
- CRF Finance
- Exchange
- REPL Nasdaq
- CRF Nasdaq
- Market Cap
- REPL 757.8M
- CRF 836.6M
- IPO Year
- REPL 2018
- CRF N/A
- Fundamental
- Price
- REPL $9.21
- CRF $7.85
- Analyst Decision
- REPL Strong Buy
- CRF
- Analyst Count
- REPL 7
- CRF 0
- Target Price
- REPL $20.83
- CRF N/A
- AVG Volume (30 Days)
- REPL 1.1M
- CRF 1.1M
- Earning Date
- REPL 08-07-2025
- CRF 01-01-0001
- Dividend Yield
- REPL N/A
- CRF 18.10%
- EPS Growth
- REPL N/A
- CRF N/A
- EPS
- REPL N/A
- CRF 1.40
- Revenue
- REPL N/A
- CRF $11,461,786.00
- Revenue This Year
- REPL N/A
- CRF N/A
- Revenue Next Year
- REPL N/A
- CRF N/A
- P/E Ratio
- REPL N/A
- CRF $5.38
- Revenue Growth
- REPL N/A
- CRF 6.53
- 52 Week Low
- REPL $6.44
- CRF $5.70
- 52 Week High
- REPL $17.00
- CRF $9.56
- Technical
- Relative Strength Index (RSI)
- REPL 53.47
- CRF 69.14
- Support Level
- REPL $9.15
- CRF $7.38
- Resistance Level
- REPL $9.64
- CRF $7.53
- Average True Range (ATR)
- REPL 0.50
- CRF 0.09
- MACD
- REPL -0.06
- CRF 0.00
- Stochastic Oscillator
- REPL 50.57
- CRF 87.59
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
About CRF Cornerstone Total Return Fund Inc. (The)
Cornerstone Total Return Fund Inc is a diversified closed-end management company. Its objective is to seek capital appreciation with current income as a secondary objective. The company invests in sectors such as Information Technology; Health Care; Financials; Communication Services; Consumer Discretionary; Industrials; Exchange-Traded Funds; Utilities; Energy; Real Estate and others.